Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REBOOT: Beta-blockers after MI without Reduced Ejection Fraction
NCT03596385Phase 4Completed
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Oct 2018
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of carvedilol in myocardial infarction (MI), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Started Oct 2018; status: completed.
02
Drugs
carvedilol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03596385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596385.